Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. COSMOS Pharmaceutical Corporation
  6. Financials
    3349   JP3298400007

COSMOS PHARMACEUTICAL CORPORATION

(3349)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: May 2018 2019 2020 2021 2022 2023
Capitalization1 464 498339 761612 599730 207--
Entreprise Value (EV)1 454 577329 286567 537678 779662 363655 809
P/E ratio 26,3x17,7x28,6x28,7x28,8x26,8x
Yield 0,38%0,58%0,36%0,31%0,35%0,38%
Capitalization / Revenue 0,83x0,56x0,90x1,00x0,95x0,89x
EV / Revenue 0,81x0,54x0,83x0,93x0,87x0,80x
EV / EBITDA 13,1x8,73x13,3x14,3x13,6x12,5x
Price to Book 4,27x2,69x4,21x4,32x3,80x3,37x
Nbr of stocks (in thousands) 39 59939 59939 59939 599--
Reference price (JPY) 11 7308 58015 47018 44018 44018 440
Announcement Date 07/12/201807/12/201907/10/2020---
1 JPY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net sales1 557 999611 137684 403727 814765 247823 399
EBITDA1 34 63437 73342 65647 32248 76652 576
Operating profit (EBIT)1 22 74924 77529 09432 83733 79436 574
Operating Margin 4,08%4,05%4,25%4,51%4,42%4,44%
Pre-Tax Profit (EBT)1 25 16727 13930 40236 83736 51339 414
Net income1 17 63319 18521 43525 44025 24027 227
Net margin 3,16%3,14%3,13%3,50%3,30%3,31%
EPS2 445484541642640688
Dividend per Share2 45,050,055,057,364,369,6
Announcement Date 07/12/201807/12/201907/10/2020---
1 JPY in Million
2 JPY
Income Statement Evolution (Quarterly data)
Fiscal Period: May 2021 Q2 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 175 014364 175177 522185 915191 352181 316
EBITDA ------
Operating profit (EBIT)1 7 63718 2927 7186 6969 1657 142
Operating Margin 4,36%5,02%4,35%3,60%4,79%3,94%
Pre-Tax Profit (EBT)1 8 23819 22112 4847 4719 6007 450
Net income1 5 58213 0728 5094 3346 7275 425
Net margin 3,19%3,59%4,79%2,33%3,52%2,99%
EPS2 14133021597,5162138
Dividend per Share ------
Announcement Date 01/12/202101/12/202104/12/2021---
1 JPY in Million
2 JPY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 9 92110 47545 06251 42967 84574 398
Leverage (Debt / EBITDA) -0,29x-0,28x-1,06x-1,09x-1,39x-1,42x
Free Cash Flow1 2 1284 33738 50511 39914 08417 270
ROE (Net Profit / Equities) 17,5%16,3%15,8%16,4%14,2%13,6%
Shareholders' equity1 100 760117 699135 665155 442178 002200 890
ROA (Net Profit / Asset) 10,6%10,4%10,6%9,53%10,4%9,13%
Assets1 166 276184 233201 651266 998241 919298 158
Book Value Per Share2 2 7503 1893 6794 2694 8485 469
Cash Flow per Share2 7458128841 1401 2251 282
Capex1 29 45129 04025 94827 23531 64331 852
Capex / Sales 5,28%4,75%3,79%3,74%4,14%3,87%
Announcement Date 07/12/201807/12/201907/10/2020---
1 JPY in Million
2 JPY
Key data
Capitalization (JPY) 730 207 330 240
Capitalization (USD) 6 620 013 329
Net sales (JPY) 684 403 000 000
Net sales (USD) 6 199 322 374
Free-Float 48,8%
Free-Float capitalization (JPY) 356 040 074 884
Free-Float capitalization (USD) 3 227 836 731
Avg. Exchange 20 sessions (JPY) 3 007 564 000
Avg. Exchange 20 sessions (USD) 27 242 515
Average Daily Capital Traded 0,4%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA